Human papillomavirus vaccine knowledge and hypothetical acceptance among women in Appalachia Ohio

Mack Ruffin, Erinn M. Hade, Melissa R. Gorsline, Cecilia R. DeGraffinreid, Mira L. Katz, Sarah C. Kobrin, Electra D. Paskett

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objective: To assess hypothetical acceptance of the human papillomavirus (HPV) vaccine for themselves and a daughter age 9-12 years among Appalachia Ohio women. Methods: Women with an abnormal Pap smear and randomly selected women with a normal Pap smear from 17 clinics completed an interview in 2006-2008. Results: From 1131 original study participants, 807 (71%) completed a survey about the HPV vaccine for their daughters and themselves. Nearly half, 380 (47%), of the participants had heard of a vaccine to prevent cancer, and 362 (95%) of respondents had heard of HPV. The participants were then told that the FDA had approved a vaccine to prevent HPV. Only 379 (38%) participants identified girls ages 9-12 years as a group who should get the vaccine. After being given the official HPV vaccine recommendation statement, 252 (31%) wanted the vaccine; 198 (25%) were "not sure"; and 353 (44%) did not want the vaccine for themselves. With respect to giving the HPV vaccine to a daughter ages 9-12 years, participants responded "yes" 445 (55%); "not sure" 163 (20%); or "no" 185 (23%). Numerous reasons were provided supporting and opposing vaccine acceptance for themselves and for a daughter. Their physician's recommendation for the HPV vaccine increased vaccine acceptance to 86% for themselves and 90% for a daughter. Conclusion: Knowledge, acceptance, and barriers about the HPV vaccine vary among women living in Appalachia Ohio. Physician recommendation is a key facilitator for vaccine diffusion in this region.

Original languageEnglish (US)
Pages (from-to)5349-5357
Number of pages9
JournalVaccine
Volume30
Issue number36
DOIs
StatePublished - Aug 3 2012

Fingerprint

Appalachian Region
Papillomavirus Vaccines
Appalachian region
Papillomaviridae
Vaccines
vaccines
Nuclear Family
Papanicolaou Test
Physicians
physicians
Interviews

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Immunology and Microbiology(all)
  • veterinary(all)
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

Ruffin, M., Hade, E. M., Gorsline, M. R., DeGraffinreid, C. R., Katz, M. L., Kobrin, S. C., & Paskett, E. D. (2012). Human papillomavirus vaccine knowledge and hypothetical acceptance among women in Appalachia Ohio. Vaccine, 30(36), 5349-5357. https://doi.org/10.1016/j.vaccine.2012.06.034
Ruffin, Mack ; Hade, Erinn M. ; Gorsline, Melissa R. ; DeGraffinreid, Cecilia R. ; Katz, Mira L. ; Kobrin, Sarah C. ; Paskett, Electra D. / Human papillomavirus vaccine knowledge and hypothetical acceptance among women in Appalachia Ohio. In: Vaccine. 2012 ; Vol. 30, No. 36. pp. 5349-5357.
@article{1b27b365320b4079b9fb16b595f35a10,
title = "Human papillomavirus vaccine knowledge and hypothetical acceptance among women in Appalachia Ohio",
abstract = "Objective: To assess hypothetical acceptance of the human papillomavirus (HPV) vaccine for themselves and a daughter age 9-12 years among Appalachia Ohio women. Methods: Women with an abnormal Pap smear and randomly selected women with a normal Pap smear from 17 clinics completed an interview in 2006-2008. Results: From 1131 original study participants, 807 (71{\%}) completed a survey about the HPV vaccine for their daughters and themselves. Nearly half, 380 (47{\%}), of the participants had heard of a vaccine to prevent cancer, and 362 (95{\%}) of respondents had heard of HPV. The participants were then told that the FDA had approved a vaccine to prevent HPV. Only 379 (38{\%}) participants identified girls ages 9-12 years as a group who should get the vaccine. After being given the official HPV vaccine recommendation statement, 252 (31{\%}) wanted the vaccine; 198 (25{\%}) were {"}not sure{"}; and 353 (44{\%}) did not want the vaccine for themselves. With respect to giving the HPV vaccine to a daughter ages 9-12 years, participants responded {"}yes{"} 445 (55{\%}); {"}not sure{"} 163 (20{\%}); or {"}no{"} 185 (23{\%}). Numerous reasons were provided supporting and opposing vaccine acceptance for themselves and for a daughter. Their physician's recommendation for the HPV vaccine increased vaccine acceptance to 86{\%} for themselves and 90{\%} for a daughter. Conclusion: Knowledge, acceptance, and barriers about the HPV vaccine vary among women living in Appalachia Ohio. Physician recommendation is a key facilitator for vaccine diffusion in this region.",
author = "Mack Ruffin and Hade, {Erinn M.} and Gorsline, {Melissa R.} and DeGraffinreid, {Cecilia R.} and Katz, {Mira L.} and Kobrin, {Sarah C.} and Paskett, {Electra D.}",
year = "2012",
month = "8",
day = "3",
doi = "10.1016/j.vaccine.2012.06.034",
language = "English (US)",
volume = "30",
pages = "5349--5357",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "36",

}

Ruffin, M, Hade, EM, Gorsline, MR, DeGraffinreid, CR, Katz, ML, Kobrin, SC & Paskett, ED 2012, 'Human papillomavirus vaccine knowledge and hypothetical acceptance among women in Appalachia Ohio', Vaccine, vol. 30, no. 36, pp. 5349-5357. https://doi.org/10.1016/j.vaccine.2012.06.034

Human papillomavirus vaccine knowledge and hypothetical acceptance among women in Appalachia Ohio. / Ruffin, Mack; Hade, Erinn M.; Gorsline, Melissa R.; DeGraffinreid, Cecilia R.; Katz, Mira L.; Kobrin, Sarah C.; Paskett, Electra D.

In: Vaccine, Vol. 30, No. 36, 03.08.2012, p. 5349-5357.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Human papillomavirus vaccine knowledge and hypothetical acceptance among women in Appalachia Ohio

AU - Ruffin, Mack

AU - Hade, Erinn M.

AU - Gorsline, Melissa R.

AU - DeGraffinreid, Cecilia R.

AU - Katz, Mira L.

AU - Kobrin, Sarah C.

AU - Paskett, Electra D.

PY - 2012/8/3

Y1 - 2012/8/3

N2 - Objective: To assess hypothetical acceptance of the human papillomavirus (HPV) vaccine for themselves and a daughter age 9-12 years among Appalachia Ohio women. Methods: Women with an abnormal Pap smear and randomly selected women with a normal Pap smear from 17 clinics completed an interview in 2006-2008. Results: From 1131 original study participants, 807 (71%) completed a survey about the HPV vaccine for their daughters and themselves. Nearly half, 380 (47%), of the participants had heard of a vaccine to prevent cancer, and 362 (95%) of respondents had heard of HPV. The participants were then told that the FDA had approved a vaccine to prevent HPV. Only 379 (38%) participants identified girls ages 9-12 years as a group who should get the vaccine. After being given the official HPV vaccine recommendation statement, 252 (31%) wanted the vaccine; 198 (25%) were "not sure"; and 353 (44%) did not want the vaccine for themselves. With respect to giving the HPV vaccine to a daughter ages 9-12 years, participants responded "yes" 445 (55%); "not sure" 163 (20%); or "no" 185 (23%). Numerous reasons were provided supporting and opposing vaccine acceptance for themselves and for a daughter. Their physician's recommendation for the HPV vaccine increased vaccine acceptance to 86% for themselves and 90% for a daughter. Conclusion: Knowledge, acceptance, and barriers about the HPV vaccine vary among women living in Appalachia Ohio. Physician recommendation is a key facilitator for vaccine diffusion in this region.

AB - Objective: To assess hypothetical acceptance of the human papillomavirus (HPV) vaccine for themselves and a daughter age 9-12 years among Appalachia Ohio women. Methods: Women with an abnormal Pap smear and randomly selected women with a normal Pap smear from 17 clinics completed an interview in 2006-2008. Results: From 1131 original study participants, 807 (71%) completed a survey about the HPV vaccine for their daughters and themselves. Nearly half, 380 (47%), of the participants had heard of a vaccine to prevent cancer, and 362 (95%) of respondents had heard of HPV. The participants were then told that the FDA had approved a vaccine to prevent HPV. Only 379 (38%) participants identified girls ages 9-12 years as a group who should get the vaccine. After being given the official HPV vaccine recommendation statement, 252 (31%) wanted the vaccine; 198 (25%) were "not sure"; and 353 (44%) did not want the vaccine for themselves. With respect to giving the HPV vaccine to a daughter ages 9-12 years, participants responded "yes" 445 (55%); "not sure" 163 (20%); or "no" 185 (23%). Numerous reasons were provided supporting and opposing vaccine acceptance for themselves and for a daughter. Their physician's recommendation for the HPV vaccine increased vaccine acceptance to 86% for themselves and 90% for a daughter. Conclusion: Knowledge, acceptance, and barriers about the HPV vaccine vary among women living in Appalachia Ohio. Physician recommendation is a key facilitator for vaccine diffusion in this region.

UR - http://www.scopus.com/inward/record.url?scp=84863992669&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863992669&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2012.06.034

DO - 10.1016/j.vaccine.2012.06.034

M3 - Article

C2 - 22749839

AN - SCOPUS:84863992669

VL - 30

SP - 5349

EP - 5357

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 36

ER -